Prestige Consumer Healthcare

Prestige Consumer Healthcare

World Rank (Aug-2026)
5675
Market Cap (Aug-2026)
2.434 Billion USD
Market Cap (Mar-08-2026)
3.179 Billion USD
World Rank (Jan-05-2024)
4,362
Market Cap (Jan-05-2024)
3.012 Billion USD
World Rank (Jul-30-2023)
4,138
Market Cap (Jul-30-2023)
3.219 Billion USD
World Rank (Jan-07-2022)
4,829
Market Cap (Jan-07-2022)
3.022 Billion USD
World Rank (Jan-01-2021)
5,899
Market Cap (Jan-01-2021)
1.747 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Nasdaq / NYSE Code
PBH
Employee Count
505
Employee Count as of Date
As on 2021
Headquarters City/State
New York
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
1,089 Million USD
Annual Operating Income in USD
309 Million USD
Annual Net Income in USD
190 Million USD
Annual Results for Period Ending
For year ending March-2026
Total Assets in USD
3,494 Million USD
Total Liabilities in USD
1,607 Million USD
Total Equity in USD
1,888 Million USD
Balance Sheet for Period Ending
As of March-2026
Business Sector
Healthcare
Personal Care Products
Company Website
PRESTIGE CONSUMER HEALTHCARE
Yahoo
Yahoo @ NYSE
Company Profile

Prestige Consumer Healthcare Manufactures and Distributes Quality in the over-the-counter Health Care and Household Cleaning Products to Retail Stores company. The company brands are digestive care, eye, ear, nose and throat, oral care, pain relief, pediatric care, skin care, sleep aids and women's health. The headquarters is in USA.

Annual Results Summary

PRESTIGE CONSUMER HEALTHCARE - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Mar-20231,127347-82 (Loss)
Mar-20221,086329205
Mar-2021943297164
Mar-2020963291142
Mar-2019975295-35 (Loss)
Balance Sheet Summary

Total Assets as on Mar-2023 was 3,353 Million USD.

Total Liabilities as on Mar-2023 was 1,906 Million USD.

Total Equity as on Mar-2023 was 1,447 Million USD.

Founded Year
1996
IPO Year
2005
Stock Exchange
Frankfurt
NYSE
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share